204 related articles for article (PubMed ID: 2237828)
1. Production of plasminogen activator and plasminogen activator inhibitor by bovine lymphatic endothelial cells: modulation by TNF-alpha.
Laschinger CA; Johnston MG; Hay JB; Wasi S
Thromb Res; 1990 Aug; 59(3):567-79. PubMed ID: 2237828
[TBL] [Abstract][Full Text] [Related]
2. Regulation of plasminogen activator and plasminogen activator inhibitor production by growth factors and cytokines in rat calvarial cells.
Cheng SL; Shen V; Peck WA
Calcif Tissue Int; 1991 Nov; 49(5):321-7. PubMed ID: 1723649
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo.
van Hinsbergh VW; Kooistra T; van den Berg EA; Princen HM; Fiers W; Emeis JJ
Blood; 1988 Nov; 72(5):1467-73. PubMed ID: 3140909
[TBL] [Abstract][Full Text] [Related]
4. Urokinase expression in mononuclear phagocytes: cytokine-specific modulation by interferon-gamma and tumor necrosis factor-alpha.
Gyetko MR; Shollenberger SB; Sitrin RG
J Leukoc Biol; 1992 Mar; 51(3):256-63. PubMed ID: 1311745
[TBL] [Abstract][Full Text] [Related]
5. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products.
van Hinsbergh VW; Bauer KA; Kooistra T; Kluft C; Dooijewaard G; Sherman ML; Nieuwenhuizen W
Blood; 1990 Dec; 76(11):2284-9. PubMed ID: 1701665
[TBL] [Abstract][Full Text] [Related]
6. Production of plasminogen activators (PAs) in bovine cumulus-oocyte complexes during maturation in vitro: effects of epidermal growth factor on production of PAs in oocytes and cumulus cells.
Park KW; Choi SH; Song XX; Funahashi H; Niwa K
Biol Reprod; 1999 Jul; 61(1):298-304. PubMed ID: 10377062
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA.
Fukumoto S; Allan EH; Yee JA; Gelehrter TD; Martin TJ
J Cell Physiol; 1992 Aug; 152(2):346-55. PubMed ID: 1322417
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells.
van Hinsbergh VW; van den Berg EA; Fiers W; Dooijewaard G
Blood; 1990 May; 75(10):1991-8. PubMed ID: 2140060
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonism by gamma-interferon.
Niedbala MJ; Picarella MS
Blood; 1992 Feb; 79(3):678-87. PubMed ID: 1732009
[TBL] [Abstract][Full Text] [Related]
10. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells.
van Hinsbergh VW; Kooistra T; Scheffer MA; Hajo van Bockel J; van Muijen GN
Blood; 1990 Apr; 75(7):1490-7. PubMed ID: 2107884
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of plasminogen activator and inhibitor in the lymphatic endothelium.
Leak LV; Saunders M; Day AA; Jones M
Microvasc Res; 2000 Nov; 60(3):201-11. PubMed ID: 11078636
[TBL] [Abstract][Full Text] [Related]
13. Effects of TGF-beta and TNF-alpha on procoagulant and fibrinolytic pathways of human tracheal epithelial cells.
Idell S; Kumar A; Zwieb C; Holiday D; Koenig KB; Johnson AR
Am J Physiol; 1994 Dec; 267(6 Pt 1):L693-703. PubMed ID: 7810674
[TBL] [Abstract][Full Text] [Related]
14. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
[TBL] [Abstract][Full Text] [Related]
15. Secretion of plasminogen activator and its inhibitor by glomerular epithelial cells.
Iwamoto T; Nakashima Y; Sueishi K
Kidney Int; 1990 Jun; 37(6):1466-76. PubMed ID: 2113968
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma modulates the fibrinolytic response in cultured human endothelial cells.
Arnman V; Stemme S; Rymo L; Risberg B
Thromb Res; 1995 Mar; 77(5):431-40. PubMed ID: 7778058
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of plasminogen activators in human gingival crevicular fluid.
Brown JM; Watanabe K; Cohen RL; Chambers DA
Arch Oral Biol; 1995 Sep; 40(9):839-45. PubMed ID: 8651888
[TBL] [Abstract][Full Text] [Related]
18. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
Orbe J; Chordá C; Montes R; Páramo JA
Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
[TBL] [Abstract][Full Text] [Related]
19. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
Lockwood CJ; Krikun G; Aigner S; Schatz F
J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
[TBL] [Abstract][Full Text] [Related]
20. Sodium hyaluronate increases the fibrinolytic response of human peritoneal mesothelial cells exposed to tumor necrosis factor alpha.
Reijnen MM; van Goor H; Falk P; Hedgren M; Holmdahl L
Arch Surg; 2001 Mar; 136(3):291-6. PubMed ID: 11231848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
